Canaccord Adams initiates coverage on Medicis Pharmaceutical (NYSE: MRX) with a Buy. Price target $35.

Canaccord analyst says, "Restylane, Perlane ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE